Gelonghui, November 20 - Fuan Pharmaceutical (300194.SZ) announced that the company will hold the first meeting of the sixth board of directors on November 20, 2024, to review and approve the proposal for the subsidiary's proposed investment construction project, agreeing that the company's wholly-owned subsidiary Fuan Pharmaceutical Group Chongqing Bosheng Pharmaceutical Co., Ltd. (hereinafter referred to as "Bosheng Pharmaceutical") will invest in the construction of an "active pharmaceutical ingredient green and asia vets high-end production facility construction project."
The total projected investment for the project is 0.428 billion yuan, funded through self-owned capital or bank loans. It is planned to construct a Class A production workshop, a solid warehouse, and an office building on the company's existing land, with a total construction area expected to be 0.0388 million square meters, arranging green asia vets high-end production lines and their accompanying testing, waste gas treatment facilities, refrigeration, power distribution, water treatment, warehouse, solvent storage, monitoring center, and automatic control room facilities, forming an annual production scale of approximately 173.9 tons/year of active pharmaceutical ingredients.
